{'fraction_non_alphanumeric': 0.02178217821782178, 'fraction_numerical': 0.0, 'mean_word_length': 5.571428571428571, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[New ral nticoagulants During Catheter Ablation of Atrial Fibrillation. Experience With Rivaroxaban].

Until recently, anticoagulant therapy after catheter ablation of atrial fibrillation, were connected with vitamin K antagonists and drugs of heparin series. New era of novel anticoagulants - dabigatran, rivaroxaban and apixaban is coming up. Our own experience of use in clinical practice of rivoroxaban for patient undergoing catheter ablation of atrial fibrillation will be discussed in this article.